miércoles, 29 de abril de 2026

Advancing Care in HER2-Mutated NSCLC: Evidence, Diagnostics, and Future Directions Authors: Balazs Halmos, MD, MS

https://www.medscape.org/viewarticle/her2-evolution-gastroesophageal-cancer-new-therapies-and-2025a1000x2t?page=1&src=mkmcmr_driv_stan_mscpedu_260428-OUS-HONC-her2-evolution-gastroesophageal-cancer-new-therapies-and-2025a1000x2t-cta&uac=148436CN

No hay comentarios:

Publicar un comentario